Sartorius Stedim Biotech S.A. buy Barclays PLC
Start price
06.01.26
/
50%
€218.80
Target price
06.01.27
-
Performance (%)
-13.72%
Price
17.04.26
€188.10
Summary
This prediction is currently active. The prediction for Sartorius Stedim Biotech S.A. disappoints with a performance of -13.72%. Dividends of €0.69 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius Stedim Biotech S.A. | 9.936% | 9.936% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Barclays_PLC for this prediction
In the thread Sartorius Stedim Biotech S.A. diskutieren
Sartorius Stedim Biotech (OTCMKTS:SDMHF) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for SDMHF provided by MarketBeat